著者
Takeo Horikoshi Takamitsu Nakamura Toru Yoshizaki Jun Nakamura Manabu Uematsu Tsuyoshi Kobayashi Yukio Saito Jun-ei Obata Takao Sawanobori Hajime Takano Ken Umetani Tetsuya Asakawa Akira Sato
出版者
The Japanese Circulation Society
雑誌
Circulation Journal (ISSN:13469843)
巻号頁・発行日
pp.CJ-23-0733, (Released:2023-12-15)
参考文献数
22

Background: Non-ST-elevation myocardial infarction (NSTEMI) carries a poor prognosis, and accurately prognostication has significant clinical importance. In this study, we analyzed the predictive value of the CHADS2, CHA2DS2-VASc, and R2-CHADS2scores for major adverse cardiac events (MACE) following percutaneous coronary intervention (PCI) in patients with NSTEMI using data from a prospective multicenter registry.Methods and Results: The registry included 440 consecutive patients with NSTEMI and coronary artery disease who underwent successful PCI. Patients were clinically followed for up to 3 years or until the occurrence of MACE. MACE was defined as a composite of all-cause death and nonfatal MI. During the follow-up period, 55 patients (12.5%) experienced MACE. Risk analysis of MACE occurrence, adjusted for the multivariable model, demonstrated a significant increase in risk with higher CHADS2, CHA2DS2-VASc, and R2-CHADS2scores. Kaplan-Meier analysis showed a higher incidence of MACE in patients with higher CHADS2, CHA2DS2-VASc, and R2-CHADS2scores, both in the short- and long-term periods.Conclusions: Patients with NSTEMI and higher CHADS2, CHA2DS2-VASc, and R2-CHADS2scores displayed a greater incidence of MACE.

言及状況

外部データベース (DOI)

Twitter (2 users, 2 posts, 0 favorites)

CHADS2, CHA2DS2-VASc and R2-CHADS2 Scores can predict Major Adverse Cardiac Event after percutaneous coronary intervention for NSTEMI. By Takeo Horikoshi https://t.co/Ajri8zVmLU #circ_j #CardioTwitter https://t.co/ZKNsuc8xbL

収集済み URL リスト